Human epidermal growth factor receptor 2 (HER2)-specific chimeric antigen receptor (CAR) for tumor immunotherapy; recent progress
Due to the overexpression or amplification of human epidermal growth factor receptor 2
(HER2) with poor prognosis in a myriad of human tumors, recent studies have focused on …
(HER2) with poor prognosis in a myriad of human tumors, recent studies have focused on …
[HTML][HTML] Current progress in chimeric antigen receptor-modified T cells for the treatment of metastatic breast cancer
L Yin, G Chen, Z **ang, Y Liu, X Li, J Bi… - Biomedicine & …, 2023 - Elsevier
Breast cancer is the leading cancer in women. Around 20–30% breast cancer patients
undergo invasion or metastasis after radical surgical resection and eventually die. Number …
undergo invasion or metastasis after radical surgical resection and eventually die. Number …
Engineering a HER2-CAR-NK cell secreting soluble programmed cell death protein with superior antitumor efficacy
W **a, J Chen, W Hou, J Chen, Y **ong, H Li… - International Journal of …, 2023 - mdpi.com
A new therapy strategy for relapsing patients who have received trastuzumab treatment
urgently needs to be explored. HER2-specific chimeric antigen receptor (CAR)-expressing …
urgently needs to be explored. HER2-specific chimeric antigen receptor (CAR)-expressing …
[HTML][HTML] Introduction on monoclonal antibodies
M Sadeghalvad, N Rezaei - Monoclonal Antibodies, 2021 - intechopen.com
Monoclonal antibodies (mAbs) are a group of antibodies produced by identical clones of B
lymphocytes against a particular antigen. mAbs are identical in several properties such as …
lymphocytes against a particular antigen. mAbs are identical in several properties such as …
Recent advances in nanoscale targeted therapy of HER2-positive breast cancer
Y Omidi, M Mobasher, AM Castejon… - Journal of Drug …, 2022 - Taylor & Francis
Breast cancer is considered as the second major cause of death among women with a high
mortality rate worldwide. The exceptionally fast rate of metastasis, the emergence of drug …
mortality rate worldwide. The exceptionally fast rate of metastasis, the emergence of drug …
Innovative Therapeutic Approaches for Patients with HER2-Positive Breast Cancer
B Taurelli Salimbeni, E Ferraro, L Boscolo Bielo… - Breast Cancer Research …, 2024 - Springer
Overexpression of human epidermal growth factor receptor 2 (HER2), a transmembrane
tyrosine kinase receptor, has been described in about 15–20% of breast cancer (BC) and is …
tyrosine kinase receptor, has been described in about 15–20% of breast cancer (BC) and is …